- Home
- ONCH vs VNDA Comparison
ONCH vs VNDA Comparison
Compare ONCH & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCH
- VNDA
- Stock Information
- Founded
- ONCH 2024
- VNDA 2002
- Country
- ONCH United States
- VNDA United States
- Employees
- ONCH N/A
- VNDA N/A
- Industry
- ONCH
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- ONCH
- VNDA Health Care
- Exchange
- ONCH Nasdaq
- VNDA Nasdaq
- Market Cap
- ONCH 221.4M
- VNDA 249.4M
- IPO Year
- ONCH 2025
- VNDA 2006
- Fundamental
- Price
- ONCH $10.39
- VNDA $5.54
- Analyst Decision
- ONCH
- VNDA Strong Buy
- Analyst Count
- ONCH 0
- VNDA 2
- Target Price
- ONCH N/A
- VNDA $16.50
- AVG Volume (30 Days)
- ONCH 23.3K
- VNDA 551.1K
- Earning Date
- ONCH 01-01-0001
- VNDA 10-29-2025
- Dividend Yield
- ONCH N/A
- VNDA N/A
- EPS Growth
- ONCH N/A
- VNDA N/A
- EPS
- ONCH N/A
- VNDA N/A
- Revenue
- ONCH N/A
- VNDA $203,467,000.00
- Revenue This Year
- ONCH N/A
- VNDA $15.45
- Revenue Next Year
- ONCH N/A
- VNDA $37.82
- P/E Ratio
- ONCH N/A
- VNDA N/A
- Revenue Growth
- ONCH N/A
- VNDA 11.78
- 52 Week Low
- ONCH $10.18
- VNDA $3.81
- 52 Week High
- ONCH $10.63
- VNDA $5.70
- Technical
- Relative Strength Index (RSI)
- ONCH N/A
- VNDA 66.36
- Support Level
- ONCH N/A
- VNDA $5.46
- Resistance Level
- ONCH N/A
- VNDA $5.70
- Average True Range (ATR)
- ONCH 0.00
- VNDA 0.18
- MACD
- ONCH 0.00
- VNDA 0.01
- Stochastic Oscillator
- ONCH 0.00
- VNDA 81.36
About ONCH 1RT Acquisition Corp. Class A Ordinary Share
1RT Acquisition Corp is a blank check company.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.